← All trials

NCT05468697

Phase 1/Phase 2Interventional

Trials that are a combination of phases 1 and 2.

View on ClinicalTrials.gov ↗

Timeline

Start date
Aug 10, 2022
Primary completion
Mar 16, 2027
Completion date
Mar 16, 2027
First posted
Jul 21, 2022
Last posted
Nov 25, 2022
Enrollment
180
Arms / groups
5 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.